Gian Marco Ludovici achieved the Bachelor’s Degree and the Master of Science Degree’s in Cell and Molecular Biology at the Department of Biology of the University of Rome “Tor Vergata”. In 2016, he achieved the Master of Philosophy (2nd Level Master Course) in Protection from CBRNe (Chemical, Biological, Radiological and Nuclear) events at the Schools of Medicine and Engineering of the University of Rome “Tor Vergata”. During his research work he worked at the Quantum Electronics and Plasma Physics Research Group of the University of Rome Tor Vergata and in the HOROS project of the University of Medicine of Innsbruck. He has also worked in international pharmaceuticals company such as Bristol–MyersSquibb and PQE.
